Aurobindo Pharma experienced a slight dip in Q4FY25 net profit, despite a revenue increase. However, the company saw ...

Aurobindo Pharma posted a marginal decrease in its net profit at ₹903 crore in the fourth quarter ended March 31, 2025.

In Q4FY25, the company's revenue from operations rose by 10.6 per cent year on year to ₹8,382 crore, with growth across its ...

Aurobindo Pharma on Monday reported a marginal dip in its consolidated profit after tax to Rs 903 crore for the fourth ...

Aurobindo Pharma's net profit declines slightly, but revenue and total expenses show significant growth in March quarter.

Our Bureau, New Delhi Wednesday, May 28, 2025, 11:15 Hrs [IST] Aurobindo Pharma has registered a marginal decline of 0 ...

On a fiscal year basis (FY25), Aurobindo Pharma’s PAT increased 10% y-o-y to ₹3,484 crore from ₹3,169 crore in FY24, showing better full year profitability. Annual income at the company also grew by a ...

Aurobindo Pharma reported a slight decline in its consolidated profit after tax to Rs 903 crore for the fourth quarter ended March 2025. Revenue grew to Rs 8,382 crore.

Aurobindo Pharma Limited reported a slight dip in its consolidated net profit for the fourth quarter ended March 31,25, despite a 10.6 per cent up in revenue.

Recently, balochistan had declared its independence from Pakistan. Baloch leader Mir Yar Baloch has also appealed to the United Nations to declare balochistan as a separate country ...